Merck announced Friday, April 12, it has signed a definitive agreement to acquire Versum Materials in a deal with an enterprise value of US$6.6 billion, according to a MarketWatch news release.
Merck will pay US$53 per Versum share in cash, the company said in a statement. Versum’s board has terminated its merger agreement with Entegris on the grounds that the Merck offer is superior.
The deal will be financed with cash on hand and debt via a facilities agreement with Bank of America Merrill Lynch, BNP Paribas Fortis, and Deutsche Bank.
The company initiated a hostile takeover after Versum initially stated it wasn’t interested in a deal. Shares in Versum have consistently traded above US$48, signaling that investors were expecting a higher price.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 216.73.216.118
Please verify email or join us
to access premium content!
